Latest market price
273.25
+2.68+0.99%
THCQT85Tenet Healthcare Corporation·NYSE
273.25+0.99%
News
Up 1.0% — Tenet Healthcare Corporation (THC) Q3 2026 Earnings Call Transcript (seekingalpha.com).
Medium confidence
TA
Loading chart...
Signal & projected range
Earnings big beat — drift (PEAD)Historical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.
Unlock with Premium

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Unlock with Premium to see the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands of historical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
Snapshot
Index—P/E7.92EPS (ttm)34.48Insider Own2.21%Shs Outstand80.52MPerf Week1.79%
Market Cap22.00BForward P/E13.15EPS next Y20.78Insider Trans-10.93%Shs Float79.75MPerf Month7.59%
Enterprise Value32.57BPEG1.08EPS next Q—Short Float2.30%Perf Quarter9.30%
Income2.90BP/S0.96EPS this Y34.91%Short Ratio2.07Perf Half Y49.10%
Sales22.80BP/B2.29EPS next Y-4.33%ROA9.18%Short Interest1.84MPerf YTD37.51%
Book/sh119.15P/C8.23EPS next 5Y9.77%ROE60.60%52W High283.05 -3.46%Perf Year30.65%
Cash/sh33.21P/FCF6.61EPS past 3/5Y59.88% 32.80%ROIC13.80%52W Low157.58 73.40%Perf 3Y406.96%
Dividend Est.—EV/EBITDA5.50Sales past 3/5Y3.58% 3.85%Gross Margin29.38%Volatility4.60% 2.90%Perf 5Y286.88%
Dividend TTM—EV/Sales1.43EPS Y/Y TTM136.33%Oper. Margin19.85%ATR (14)8.77Perf 10Y1061.78%
Dividend Ex-DateMar 13, 2000Quick Ratio1.52Sales Y/Y TTM9.33%Profit Margin12.71%RSI (14)58.16Recom2.19
Dividend Gr. 3/5Y—Current Ratio1.58EPS Q/Q79.46%SMA202.30%Beta1.19Target Price288.00
Payout0.00%Debt/Eq1.38Sales Q/Q18.68%SMA503.16%Rel Volume1.63Prev Close270.57
Employees88,500LT Debt/Eq1.36EarningsFeb 10SMA20024.09%Avg Volume743.63KPrice273.25
IPO DateMar 17, 1980Option/ShortYes / YesEPS/Sales Surpr.42.01% 2.59%Net Debt/EBITDA1.79Volume1,209,361Change0.99%
Analyst Ratings
DateActionAnalystRatingTarget
Oct-16-26ReiteratedGuggenheimBuy$242 → $307
Sep-22-26InitiatedBMO CapitalMarket Perform$265
Aug-14-26ReiteratedRaymond JamesOutperform$275 → $285
Aug-10-26ReiteratedMizuho SecuritiesOutperform$250 → $290
Aug-03-26ReiteratedWells FargoOverweight$231 → $281
Jul-28-26ReiteratedGoldman SachsNeutral$252 → $305
Jul-28-26ReiteratedRobert W. Baird$210 → $280
Jul-28-26ReiteratedTruist SecuritiesBuy$270 → $290
Jul-27-26ReiteratedStephensOverweight$250 → $285
Jul-27-26ReiteratedPiper Sandler$308
Latest News· Times ET
Oct-30-26
Oct-30-2610:14PM
Oct-29-26
Oct-28-26
Oct-27-26
Oct-23-26
Oct-22-26
Company

Tenet Healthcare Corporation operates as a broad-ranging provider of health solutions. The company organizes its operations across three main divisions: Hospital Operations and Other, Ambulatory Care, and Conifer. Within its network of acute care facilities, Tenet delivers a full spectrum of essential services. These include core hospital functions such as operating and recovery suites, radiology and respiratory therapy, clinical laboratories, and on-site pharmacies. The organization also provides high-acuity patient care through intensive, critical, and coronary care units. Specialized medical services cover areas like cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics, alongside various outpatient treatments, including physical therapy. Advanced surgical capabilities feature cardiothoracic, complex spinal, and neurosurgery, as well as neonatal intensive care. Tenet extends its offerings to ultra-specialized quaternary care, exemplified by heart and kidney transplant programs, and sophisticated procedures such as limb-salvaging vascular interventions, acute Level 1 trauma care, intravascular stroke treatment, minimally invasive cardiac valve replacements, advanced imaging, and telemedicine access. Beyond its hospital network, Tenet manages numerous other clinical sites. These encompass outpatient surgical centers, immediate care facilities, diagnostic imaging centers, dedicated surgical hospitals, off-campus emergency departments, and micro-hospitals. Through its Conifer segment, the company furnishes critical healthcare business process solutions. These administrative services, offered to hospitals, health systems, physician practices, employers, and other clients, include financial administration for patient accounts (revenue cycle management), support for patient communications and engagement, and outcome-focused care strategies. As of February 9, 2022, Tenet's operational footprint included 60 hospitals and roughly 550 additional medical facilities. This count of additional sites comprises surgical hospitals, ambulatory surgery centers, urgent care and imaging centers, and various other clinical locations. Tenet Healthcare Corporation was established in 1975 and maintains its principal office in Dallas, Texas.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue22,80021,31020,66520,548—————
Cost of Goods Sold Incl. D&A16,1023,78012,45612,743—————
Gross Profit6,69817,5308,2097,805—————
Selling, General and Administrative Excl. Other6,5788,7058,801418—————
Research and Development
0000—————
Other Operating Expense-4,4055,386-6,5484,877—————
Operating Income4,5253,4395,9562,510—————
Interest Expense817821826901—————
Unusual Expense
—————————
Non-Operating Income (Expense)1,0241821188—————
Net Income Before Taxes4,7322,8005,2481,617—————
Income Taxes9184331,184306—————
Consolidated Net Income2,8991,4073,200611—————
Net Income From Continuing Operations3,8142,3674,0641,311—————
Net Income2,8991,4073,200611—————
EPS (Recurring)34.7115.6133.026.01—————
EPS (Basic, Before Extraordinaries)34.7115.6133.026.01—————
EPS (Diluted)34.4815.4932.705.71—————
EBITDA5,9214,4846,8923,388—————
Other After Tax Adjustments
—————————
Stock Option Compensation Expense
—————————
Price To Earnings Ratio7.9212.833.8613.23—————
Price To Sales Ratio0.960.840.590.38—————
Gross Margin29.3882.2639.7237.98—————
Operating Margin19.8516.1428.8212.22—————
Net Margin12.716.6015.492.97—————
Shares Outstanding809097102—————
Market Capitalization21,86017,88512,2447,708—————
Operating Lease Expense
—————————
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$298.68$259.87$221.07$182.26$143.46● Close Price0.00M9.12M18.25M27.37M36.50MUSD Trades VolumeNovDec2026FebMarAprMayJunJulAugSepOctNov
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
KERREY J ROBERTDirectorSep 14 '26Sale263.7212,0103,167,3304,794Sep 16
MARK RICHARD JDirectorSep 10 '26Sale263.4210,0002,634,20025,121Sep 14
West NadjaDirectorSep 02 '26Sale258.801,152298,13823,653Sep 03
Foo Lisa YEVP, Chief Operating OfficerAug 31 '26Sale266.3224,0006,391,6808,053Sep 01
Sutaria SaumyaCEOAug 25 '26Sale274.0250,00013,701,076433,564Aug 26
Sutaria SaumyaCEOAug 24 '26Sale278.7150,00013,935,258483,564Aug 26
HANEY CECIL DDirectorAug 24 '26Sale278.031,300361,43912,553Aug 26
Romo TammyDirectorAug 07 '26Sale260.832,500652,07528,284Aug 10
Romo TammyDirectorAug 06 '26Sale264.154,9221,300,14630,784Aug 10
Blunt RoyDirectorAug 05 '26Sale262.68600157,6084,589Aug 07
Foo Lisa YEVP, Chief Operating OfficerJul 29 '26Sale258.0310,0002,580,30032,053Jul 31
Arbour Paola MEVP, Chief Information OfficerJul 27 '26Sale243.9010,8782,653,14418,413Jul 28
Lynch Christopher S.DirectorJul 27 '26Sale243.443,837934,0799,568Jul 28
BIERMAN JAMES LDirectorJul 27 '26Sale244.965,0001,224,80031,604Jul 28
KERREY J ROBERTDirectorMay 28 '26Sale174.525,638983,92016,804May 29
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.